| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/29/2013 | CN103120694A Application of Gypensapogenin B in antidepressant drug |
| 05/29/2013 | CN103120693A Composition of anti-hair-loss agent |
| 05/29/2013 | CN103120692A Preparation method for injection cefoperazone sodium tazobactam sodium composition |
| 05/29/2013 | CN103120691A Application of fuziline in preparation of medicine for preventing and treating shock |
| 05/29/2013 | CN103120690A Pharmaceutical composition for treatment of cataract |
| 05/29/2013 | CN103120689A Application of pyrazol compound as mycobacterium tuberculosis inhibitor |
| 05/29/2013 | CN103120688A Pharmaceutical composition of flash release preparation |
| 05/29/2013 | CN103120687A Application of Eryngiolide A in medicine for resisting tubercle bacillus |
| 05/29/2013 | CN103120686A Application of Aphanamixoid A in medicine for preventing or treating pancreatic fibrosis |
| 05/29/2013 | CN103120685A Application of Aphanamixoid A in medicine for increasing erythrocytes |
| 05/29/2013 | CN103120684A Application of Aphanamixoid A in medicine for treating endometrial carcinoma |
| 05/29/2013 | CN103120683A Application of Aphanamixoid A in prevention and treatment of hepatic injury |
| 05/29/2013 | CN103120682A Application of Aphanamixoid A in medicine for treating bladder cancer |
| 05/29/2013 | CN103120681A Application of Aphanamixoid A in medicine for resisting lung cancer metastasis |
| 05/29/2013 | CN103120680A Application of Aphanamixoid A in medicine for treating nasopharyngeal carcinoma |
| 05/29/2013 | CN103120679A Application of Aphanamixoid A in medicine for treating tongue cancer |
| 05/29/2013 | CN103120678A Application of Aphanamixoid A in medicine for treating liver cancer |
| 05/29/2013 | CN103120677A Application of Aphanamixoid A in medicine for treating or preventing renal fibrosis |
| 05/29/2013 | CN103120676A Application of Eryngiolide A in medicine for treating rheumatoid arthritis |
| 05/29/2013 | CN103120675A Application of Eryngiolide A in medicine for treating atherosclerosis |
| 05/29/2013 | CN103120674A Application of Eryngiolide A in preparation of MAO (Monoamine Oxidottom) inhibitor |
| 05/29/2013 | CN103120673A Application of Aphanamixoid A to preparation of monoamine oxidase (MAO) inhibitor |
| 05/29/2013 | CN103120672A Application of Aphanamixoid A in medicine for preventing and treating chronic obstructive pulmonary disease |
| 05/29/2013 | CN103120671A Application of Aphanamixoid A in medicine for treating rheumatoid arthritis |
| 05/29/2013 | CN103120670A Application of Eryngiolide A in medicine for treating or preventing acute heart failure |
| 05/29/2013 | CN103120669A Application of Eryngiolide A in medicine for treating rhinitis |
| 05/29/2013 | CN103120668A Application of Eryngiolide A in anti-helicobacter pylori drug |
| 05/29/2013 | CN103120667A Application of Aphanamixoid A in medicine for preventing and treating renal insufficiency |
| 05/29/2013 | CN103120666A Application of Aphanamixoid A in medicine for treating human cervical carcinoma |
| 05/29/2013 | CN103120665A Application of Aphanamixoid A in medicine for treating prostatic cancer |
| 05/29/2013 | CN103120664A Application of Eryngiolide A in medicine for resisting hypoxia |
| 05/29/2013 | CN103120663A Application of Eryngiolide A in vascular dilation drug |
| 05/29/2013 | CN103120662A Application of Eryngiolide A in medicine for treating dengue virus infection |
| 05/29/2013 | CN103120661A Application of Eryngiolide A in medicine for resisting influenza A virus |
| 05/29/2013 | CN103120660A Application of Eryngiolide A in medicine for preventing or treating pancreatic fibrosis |
| 05/29/2013 | CN103120659A Application of Eryngiolide A in antidepressant drug |
| 05/29/2013 | CN103120658A Application of Eryngiolide A in medicine for resisting aseptic inflammation |
| 05/29/2013 | CN103120657A Application of Eryngiolide A in medicine for increasing red blood cells |
| 05/29/2013 | CN103120656A Danshinolic acid A tablet and application thereof for preparing medicines |
| 05/29/2013 | CN103120655A Composition for amelioration/prevention of adverse side effect in steroid therapy |
| 05/29/2013 | CN103120654A Application of lanthanum acetate or hydrates for treating hyperphosphatemia |
| 05/29/2013 | CN103120653A Oral pharmaceutical composition |
| 05/29/2013 | CN103120652A 间苯三酚口腔崩解片及其制备方法 Among the three phenols orally disintegrating tablets and its preparation method benzene |
| 05/29/2013 | CN103120651A Manidipine tablet |
| 05/29/2013 | CN103120650A Rupatadine fumarate tablet |
| 05/29/2013 | CN103120649A Application of salvianolic acid freeze-dried powder injection for preparing medicine for inhibiting brain neuron damage or death |
| 05/29/2013 | CN103120648A Oral isoprinosine preparation and preparation method thereof |
| 05/29/2013 | CN103120647A Method for preparing omeprazole sustained-release microspheres by emulsified solvent diffusion method |
| 05/29/2013 | CN103120646A Polaprezinc granules and preparation method thereof |
| 05/29/2013 | CN103120645A Irinotecan or irinotecan hydrochloride lipidosome and preparation method thereof |
| 05/29/2013 | CN103120643A Curcumin dicaprate suspension injection and preparation method and application thereof |
| 05/29/2013 | CN103120642A Gel used for skin diseases and preparation method thereof |
| 05/29/2013 | CN103120641A Graphene oxide supported benazepril compound as well as preparation method and application thereof |
| 05/29/2013 | CN103120624A 6'-O-caffeoyl-arbutin and derivatives thereof, and application of compound prescription in preparing cosmetics or medicines |
| 05/29/2013 | CN103120509A Drug pillow |
| 05/29/2013 | CN103120310A Preparation method of resveratrol water-soluble dry powder |
| 05/29/2013 | CN102920703B Preparation method for lansoprazole for injection |
| 05/29/2013 | CN102755325B Cefoxitin sodium medicinal composition, powder injection and preparation method thereof |
| 05/29/2013 | CN102743351B Pantoprazole sodium freeze-dried medicinal composition and preparation method thereof |
| 05/29/2013 | CN102719397B Mesenchymal stem cell and application thereof in resisting HIV-1 (human immunodeficiency virus) |
| 05/29/2013 | CN102657658B Medicine composition for treating myocardial infarction, vascular circulatory disturbance and thrombosis |
| 05/29/2013 | CN102631330B Lansoprazole vesicle type phospholipid gel slow release solid preparation |
| 05/29/2013 | CN102626392B Solid preparation of doxycycline ambroxol medicine compound |
| 05/29/2013 | CN102626390B Gastrodin multiphase liposome injection |
| 05/29/2013 | CN102626389B Ornidazole liposome injection |
| 05/29/2013 | CN102626388B Liposome solid preparation of ozagrel |
| 05/29/2013 | CN102626381B Vesicular phospholipid gel injection of latamoxef sodium |
| 05/29/2013 | CN102614182B Solid preparation of compound ammonia phenol renin medicine composition liposome |
| 05/29/2013 | CN102600173B Amlodipine/benazepril medicament composition liposome solid preparation |
| 05/29/2013 | CN102558393B Preparation process of dalteparin sodium |
| 05/29/2013 | CN102552273B Composition containing epigallocatechin gallate and methotrexate |
| 05/29/2013 | CN102552244B Composition for inhibiting tumor cell proliferation by using epigallocatechin gallate and carboplatin |
| 05/29/2013 | CN102552140B Liquid medicine composition of rosiglitazone |
| 05/29/2013 | CN102526082B Compound glycyrrhizin soluble powder for livestock and preparation method thereof |
| 05/29/2013 | CN102516388B Anthropogenic LMP1 (latent membrane protein1) extracellular regional antibody for nasopharyngeal carcinoma and application thereof |
| 05/29/2013 | CN102485218B Clopidogrel hydrogen sulfate tablet and preparation method thereof |
| 05/29/2013 | CN102429900B Application of natural compound P25 in inhibiting reproduction and growth of tumour cells |
| 05/29/2013 | CN102429898B Application of natural compound P47 in inhibiting reproduction and growth of tumour cells |
| 05/29/2013 | CN102429879B Ambroxol hydrochloride liposome injection |
| 05/29/2013 | CN102423293B Microemulsion gel preparation of oxiconazole nitrate |
| 05/29/2013 | CN102397287B Application of opuntia ficus-indica polysaccharide in preparation of medicine with hypolipidemic effect |
| 05/29/2013 | CN102397286B Application of prickly pear polysaccharide in preparation of medicament or health-care product with hypoglycemic effect |
| 05/29/2013 | CN102391263B Deuteroacetyl-containing kinase inhibitor |
| 05/29/2013 | CN102370648B Medicinal composition and its application |
| 05/29/2013 | CN102366416B Pharmaceutical application of 12-dehydroxy-21-hydroxy protopanoxadiol |
| 05/29/2013 | CN102327278B Application of carborane derivatives, nano compound preparation and application of nano compound preparation |
| 05/29/2013 | CN102309493B Anti-cancer medicinal composition |
| 05/29/2013 | CN102309472B Compound essential oil with anti-free radical function |
| 05/29/2013 | CN102258564B Medicine for improving immunity in a microgravity environment and screening method thereof |
| 05/29/2013 | CN102247368B Compound acrivastine sustained release tablets, and preparation method thereof |
| 05/29/2013 | CN102219750B N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
| 05/29/2013 | CN102206180B Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors |
| 05/29/2013 | CN102204968B External defervescence liquid medicine for treating infant anemopyretic cold |
| 05/29/2013 | CN102204887B In-situ formed acyclovir spraying agent and preparation method thereof |
| 05/29/2013 | CN102188674B Health-care liquid for promoting blood circulation, removing blood stasis and freeing bi |
| 05/29/2013 | CN102178659B Clarithromycin entericcoated tablet and preparation method thereof |
| 05/29/2013 | CN102151336B Active targeting drug conveying system for crossing blood brain barrier through mediation of acetylcholine receptor |
| 05/29/2013 | CN102146056B N-benzyl-acridone, derivatives of N-benzyl-acridone and preparation methods and application of N-benzyl-acridone and derivatives |
| 05/29/2013 | CN102140092B Hydrate of ilaprazole salt, preparation method thereof and application thereof |
| 05/29/2013 | CN102133193B Faropenem sodium powder injection |